<DOC>
	<DOCNO>NCT00881439</DOCNO>
	<brief_summary>The main purpose study examine effect add-on therapy direct renin inhibitor Aliskiren comparison placebo renal blood flow patient heart failure reduce renal function . - Primary outcome measure : change renal blood flow 6 month - Secondary outcome measure : change renal function , N-terminal pro Brain natriuretic peptide , leave ventricular function , blood pressure neurohormone</brief_summary>
	<brief_title>Safety Efficacy Study Add On Aliskiren Patients With Heart Failure Renal Impairment</brief_title>
	<detailed_description>This study randomize , double-blind , placebo control , parallel group comparison trial , enrol 100 patient ( 67 vs. 33 ) stable CHF . Patients randomize Aliskiren 300 mg daily correspond Placebo period 6 month . Efficacy measure perform baseline end study . Primary efficacy outcome change renal blood flow measure 131I-Hippuran clearance . Secondary outcome include change renal function , neurohormone , leave ventricular function blood pressure . Safety assessment include renal function , change electrolyte , blood pressure . Patients uptitrated maximum tolerated dos Aliskiren , safety visit plan 1 week initiation 2 month interval afterwards . A total 8 visit plan entire study period .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>NYHA IIIV Heart Failure Left ventricular ejection fraction &lt; 45 % Stable heart failure medication eGFR sMDRD formula 30 60 mL/min/1.73m2 Known hypersensitivity study drug ACEi Concomitant treatment ARB Aldosterone Receptor Antagonist Symptomatic Hypotension Acute Heart Failure History stroke , acute coronary syndrome , PCI angioplasty within past 3 month Serum potassium &gt; 5.2 mmol/L Right heart failure due severe pulmonary disease Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Renal Failure</keyword>
	<keyword>Cardiorenal Syndrome</keyword>
	<keyword>Renin inhibition</keyword>
	<keyword>Aliskiren</keyword>
</DOC>